Sentiance uses ambient intelligence to enable contextual and situational experiences to smart-phones, wearables and connected devices.
Sentiance uses ambient intelligence to enable contextual and situational experiences to smart-phones, wearables and connected devices. Sentiance successfully unlocks the power of contextualization through its sensor and mobile platform, and enables industries worldwide to tap into a new level of personalization and engagement. From mobile data to smart life. Sentiance implements technology developed at the VUB and Ghent University.
Animab develops antibodies to tackle gastrointestinal pathogens in livestock.
EyeD Pharma is developing micro-implants for drug release over a prolonged period of time.
ABSCINT is developing single-domain antibodies for disease diagnosis through imaging.
